DUBLIN--(http://www.researchandmarkets.com/research/xwfnd5/chinese_markets) has announced the addition of the "Chinese Markets for Health Care" report to their offering.)--Research and Markets (
China's demand for health care has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
Lizhu Pharmaceutical Group Stockholder- owned Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Shandong Lukang Pharmaceutical Group Co., Ltd.
Taiji Pharmaceutical Group Co., Ltd.
Hearts K Group Stockholder-owned Co., Ltd.
Sino-America Tianjian Shike Pharmaceutical Co., Ltd.
Hebei Gaoying Enterprise Group Corporation
Sino-America Shanghai Shibaogui Pharmaceutical Co., Ltd.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. HEALTH CARE INDUSTRY ASSESSMENTS
IV. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS
V. HEALTH CARE MARKET OUTLOOKS
VI. MARKETING STRATEGIES
VII. HEALTH CARE PRODUCER DIRECTORY
LIST OF TABLES
LIST OF CHARTS
For more information visit http://www.researchandmarkets.com/research/xwfnd5/chinese_markets